from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0376c/-

LFCtreatmentdescriptionclass of inhibitor

-0.279

Amikacinug/mL Amikacintranslation

0.279

Cap5-10ug/mL Capreomycintranslation

-0.030

Rox10-50 ug/mL Roxithromycintranslation

-0.871

SM2-5 ug/mL Streptomycintranslation

-0.534

Tet5-10 ug/mL Tetracyclinetranslation

0.799

Rif0.2-5ug/mL Rifampicintranscription

0.473

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.272

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.203

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.298

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.312

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.087

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.452

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.952

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.893

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.753

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.005

Nigericin50 uM Nigericinrespiration

0.218

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.066

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.666

menadione6-10 ug/mL Menadionerespiration

0.189

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.266

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.314

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.260

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.643

NRP_1Non-replicating persistence stage 1dosRassociated

-0.360

Amp0.2mg/mL AmpicillincellWall

-0.208

Cephalexin20-100 ug/mL CephalexincellWall

-0.279

Cerulenin0.32-5 ug/mL CerulenincellWall

0.544

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.025

EMB10-20 ug/mL EthambutolcellWall

-1.432

Eta12-40 ug/mL EthionamidecellWall

-1.917

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.461

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.324

BZA0.12 mg/mL BenzamidearomaticAmides

-0.366

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.529

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.913

H2O24 mM hydrogen peroxideDNAdamaging

0.174

Levo10 ug/mL LevofloxacinDNAdamaging

0.274

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.497

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.824

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.703

Antimycin12.5-50 ug/mL Antimycin A?

1.929

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.359

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.262

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.060

PA8240.2-2 ug/mL PA-824?

-0.049

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.008

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

2.062

methoxatin10-20 ug/mL Methoxatin?